CytoHub, Inc.

We develop an integrated biotechnology platform designed to deliver tools and technologies that enhance drug discovery and regenerative medicine.

Large market opportunity, demonstrated use cases, unique competitive differentiation, experienced leadership team.
Raised: $300K in service revenues, 4 signed contracts, partnership with NVIDIA, operating at JLABS in San Diego.

Drug discovery and regenerative medicine.

Proprietary technology CardioVive™, PSC-derived products, BioEngineAI™, 4 patents.

In vitro testing $100K/ test plate; Disease Modeling $350K/ disease model; Drug Discovery/ Therapeutic Pipeline, Strategic Partnership; Regenerative Medicines, Strategic Partnership. 37B SOM. $144M projected revenue by 2028.

Stanford, LISA